PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium

Lymphoepithelioma-like carcinoma of the endometrium is a very rare variant of endometrial carcinoma characterized by syncytial nests of pleomorphic epithelial cells and heavy infiltration of the stroma by lymphocytes (in particular CD8 cytotoxic T-lymphocytes) and plasma cells. Until now, only five...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucie Bienfait, Nicky D’Haene, Xavier Catteau, Jean-Christophe Noël
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Pathology
Online Access:http://dx.doi.org/10.1155/2018/5894589
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548869132517376
author Lucie Bienfait
Nicky D’Haene
Xavier Catteau
Jean-Christophe Noël
author_facet Lucie Bienfait
Nicky D’Haene
Xavier Catteau
Jean-Christophe Noël
author_sort Lucie Bienfait
collection DOAJ
description Lymphoepithelioma-like carcinoma of the endometrium is a very rare variant of endometrial carcinoma characterized by syncytial nests of pleomorphic epithelial cells and heavy infiltration of the stroma by lymphocytes (in particular CD8 cytotoxic T-lymphocytes) and plasma cells. Until now, only five cases have been characterized in this location. This report describes the clinicopathological and the molecular features of this unusual tumor. In particular, using the next generation sequencing (NGS) technique, we have demonstrated that this tumor could be associated with PIK3CA and p53 gene mutations. These data have not been reported to date and suggest that lymphoepithelioma-like carcinoma of the endometrium shares common molecular features with high grade endometrioid and serous-like endometrial carcinoma which are associated with poor outcome. Nevertheless, in endometrial lymphoepithelioma-like carcinoma, the alterations on cell cycle, apoptosis, and/or senescence secondary to p53 mutations could potentially be counterbalanced by the antitumoral response induced by CD8 cytotoxic T-lymphocytes numerous in these tumors.
format Article
id doaj-art-28c713ab767045c1868f74857ccbb108
institution Kabale University
issn 2090-6781
2090-679X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Pathology
spelling doaj-art-28c713ab767045c1868f74857ccbb1082025-02-03T06:12:44ZengWileyCase Reports in Pathology2090-67812090-679X2018-01-01201810.1155/2018/58945895894589PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the EndometriumLucie Bienfait0Nicky D’Haene1Xavier Catteau2Jean-Christophe Noël3Department of Pathology, Erasme University Hospital/Curepath, Free University of Brussels (ULB), Brussels, BelgiumDepartment of Pathology, Erasme University Hospital/Curepath, Free University of Brussels (ULB), Brussels, BelgiumDepartment of Pathology, Erasme University Hospital/Curepath, Free University of Brussels (ULB), Brussels, BelgiumDepartment of Pathology, Erasme University Hospital/Curepath, Free University of Brussels (ULB), Brussels, BelgiumLymphoepithelioma-like carcinoma of the endometrium is a very rare variant of endometrial carcinoma characterized by syncytial nests of pleomorphic epithelial cells and heavy infiltration of the stroma by lymphocytes (in particular CD8 cytotoxic T-lymphocytes) and plasma cells. Until now, only five cases have been characterized in this location. This report describes the clinicopathological and the molecular features of this unusual tumor. In particular, using the next generation sequencing (NGS) technique, we have demonstrated that this tumor could be associated with PIK3CA and p53 gene mutations. These data have not been reported to date and suggest that lymphoepithelioma-like carcinoma of the endometrium shares common molecular features with high grade endometrioid and serous-like endometrial carcinoma which are associated with poor outcome. Nevertheless, in endometrial lymphoepithelioma-like carcinoma, the alterations on cell cycle, apoptosis, and/or senescence secondary to p53 mutations could potentially be counterbalanced by the antitumoral response induced by CD8 cytotoxic T-lymphocytes numerous in these tumors.http://dx.doi.org/10.1155/2018/5894589
spellingShingle Lucie Bienfait
Nicky D’Haene
Xavier Catteau
Jean-Christophe Noël
PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
Case Reports in Pathology
title PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
title_full PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
title_fullStr PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
title_full_unstemmed PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
title_short PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
title_sort pik3ca and p53 mutations by next generation sequencing in lymphoepithelioma like carcinoma of the endometrium
url http://dx.doi.org/10.1155/2018/5894589
work_keys_str_mv AT luciebienfait pik3caandp53mutationsbynextgenerationsequencinginlymphoepitheliomalikecarcinomaoftheendometrium
AT nickydhaene pik3caandp53mutationsbynextgenerationsequencinginlymphoepitheliomalikecarcinomaoftheendometrium
AT xaviercatteau pik3caandp53mutationsbynextgenerationsequencinginlymphoepitheliomalikecarcinomaoftheendometrium
AT jeanchristophenoel pik3caandp53mutationsbynextgenerationsequencinginlymphoepitheliomalikecarcinomaoftheendometrium